Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression
Anita Mohite1, Annirudha Chillar, Shui-Ping So
1Center for Experimental Therapeutics and PharmacoInformatics and Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77004, United States.
Abstract:
Prostacyclin (PGI(2)) is a key vascular protector, metabolized from endogenous arachidonic acid (AA). Its actions are mediated through the PGI(2) receptor (IP) and nuclear receptor, peroxisome proliferator-activated receptor γ (PPARγ). Here, we found that PGI(2) is involved in regulating cellular microRNA (miRNA) expression through its receptors in a mouse adipose tissue-derived primary culture cell line expressing a novel hybrid enzyme gene (COX-1-10aa-PGIS), cyclooxygenase-1 (COX-1) and PGI(2) synthase (PGIS) linked with a 10-amino acid linker. The triple catalytic functions of the hybrid enzyme in these cells successfully redirected the endogenous AA metabolism toward a stable and dominant production of PGI(2). The miRNA microarray analysis of the cell line with upregulated PGI(2) revealed a significant upregulation (711, 148b, and 744) and downregulation of miRNAs of interest, which were reversed by antagonists of the IP and PPARγ receptors. Furthermore, we also found that the insulin-mediated lipid deposition was inhibited in the PGI(2)-upregulated adipocytes. The study also initiated a discussion that suggested that the endogenous PGI(2) inhibition of lipid deposition in adipocytes could involve miRNA-mediated inhibition of expression of the targeted genes. This indicated that PGI(2)-miRNA regulation could exist in broad pathophysiological processes involving PGI(2) (i.e., apoptosis, vascular inflammation, cancer, embryo implantation, and obesity).
Insights
Prostacyclin (PGI(2)) regulates microRNA (miRNA) expression via its receptors. This study demonstrates PGI(2) influences lipid deposition in adipocytes, suggesting a role in various diseases.
Area of Science:
- Endocrinology
- Molecular Biology
- Vascular Biology
Background:
- Prostacyclin (PGI(2)) is a crucial vascular protector derived from arachidonic acid (AA).
- PGI(2) exerts its effects through the prostacyclin receptor (IP) and peroxisome proliferator-activated receptor gamma (PPARγ).
Purpose of the Study:
- To investigate the role of PGI(2) in regulating microRNA (miRNA) expression.
- To explore the impact of PGI(2)-mediated miRNA changes on adipocyte function and lipid deposition.
Main Methods:
- Utilized a novel hybrid enzyme (COX-1-10aa-PGIS) to achieve stable, dominant PGI(2) production in mouse adipose-derived cells.
- Conducted miRNA microarray analysis to identify differentially expressed miRNAs.
- Administered IP and PPARγ receptor antagonists to assess their effect on miRNA expression.
- Investigated the effect of PGI(2) upregulation on insulin-mediated lipid deposition in adipocytes.
Main Results:
- Upregulation of PGI(2) significantly altered the expression of specific miRNAs (711, 148b, 744).
- These miRNA changes were reversible with IP and PPARγ receptor antagonists.
- Increased PGI(2) levels inhibited insulin-mediated lipid deposition in adipocytes.
- A potential mechanism involving miRNA-mediated gene expression inhibition was proposed.
Conclusions:
- PGI(2) regulates cellular miRNA expression through IP and PPARγ receptors.
- PGI(2)-miRNA interactions may play a role in inhibiting lipid deposition in adipocytes.
- This PGI(2)-miRNA regulatory axis could be relevant in pathophysiological processes including apoptosis, vascular inflammation, cancer, embryo implantation, and obesity.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
MicroRNAs
MicroRNAs
MicroRNAs
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Mechanism of Angiogenesis

